About
This clinical decision-support tool aids healthcare professionals in assessing and managing acute pulmonary embolism. It provides structured risk stratification, treatment guidance, and educational resources based on patient vitals, imaging, and biomarkers.
What's New in PE Compass
1.0
July 11, 2026
Developer apps
FAQ
What is PE Compass?
PE Compass is a clinical decision-support tool designed for licensed healthcare professionals to rapidly assess and manage acute pulmonary embolism (PE). It helps stratify risk and provides guidance based on patient data.
Who is PE Compass intended for?
This tool is exclusively for licensed healthcare professionals, such as PERT members, interventional radiologists, emergency physicians, and intensivists, who are involved in the care of patients with acute pulmonary embolism.
Does PE Compass provide medical advice?
No, PE Compass is intended for educational and clinical decision-support purposes only. It does not provide medical advice, make diagnoses, or replace the independent judgment of the treating clinician.
What scoring systems are integrated into PE Compass?
PE Compass integrates the sPESI, BOVA, and NEWS scoring systems, along with an AHA/ACC A-E classification framework with a respiratory modifier (+R).
Can I share patient assessments from PE Compass?
Yes, you can share a concise report directly from the app. Clinical calculations run on your device, and data is only transmitted if you explicitly save an assessment to your account.
Does PE Compass have ads?
No, PE Compass is ad-free. It does not feature third-party advertising or analytics tracking, ensuring a focused user experience for healthcare professionals.
What devices does PE Compass support?
PE Compass is currently available for iPhone and iPod devices. It is designed for mobile use in clinical settings.
How often is PE Compass updated?
PE Compass was last updated on July 11, 2026, with version 1.0. Future updates will likely align with new clinical guidelines or feature enhancements.